Intuitive Surgical da Vinci 5 Procedure Growth Fears: Why a 40%+ Selloff Hands Long-Term Investors a Wide-Moat Compounder at 29x Forward Earnings
Intuitive Surgical (ISRG) da Vinci procedure growth fears drove a 40%+ selloff. At 29x forward earnings with a wide moat, here is why ISRG is a Buy.
